Mitobridge
Latest round
- Series A
Last raised
- Oct 2013
Total raised
- $5.2M
Investors
- 3
About Mitobridge
, is a biopharmaceutical company that develops small molecule therapeutics to improve mitochondrial functions and to treat diseases with a high unmet medical need.
Who invested in Mitobridge
3 investors across 1 round
See all investors in Mitobridge
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 17, 2013
Amount
$5.2M
Investors
Questions about Mitobridge
Who invested in Mitobridge?
Mitobridge has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mitobridge raised?
Mitobridge has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mitobridge last raise money?
Mitobridge's most recent round on record is a Series A, in Oct 2013.
What does Mitobridge do?
, is a biopharmaceutical company that develops small molecule therapeutics to improve mitochondrial functions and to treat diseases with a high unmet medical need.
Where is Mitobridge headquartered?
Mitobridge is headquartered in Cambridge, US.
Which VCs invest in companies like Mitobridge?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mitobridge's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Mitobridge? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.